What is semaglutide in simple terms?

Semaglutide is an active ingredient used in several prescription GLP-1 receptor agonist medicines. In the United States, current labels connect semaglutide with brands including Ozempic, Wegovy, and Rybelsus, but the active ingredient alone does not indicate the product's approved use.

Is semaglutide the same as Ozempic?

No. Semaglutide is the active ingredient. Ozempic is a brand name for specific semaglutide products used in type 2 diabetes management. Wegovy and Rybelsus also contain semaglutide, but their routes and labels differ.

Is semaglutide available as a pill?

Yes. Current U.S. labeling includes oral semaglutide tablets under Rybelsus, Ozempic, and Wegovy. Tablet products have their own specific labels and are not interchangeable with injectable products.

How are Ozempic, Wegovy, and Rybelsus different?

They are distinct brands of semaglutide. Ozempic is indicated for type 2 diabetes, Wegovy for weight management and related cardiovascular contexts, and Rybelsus is an oral formulation for type 2 diabetes. Exact indications are found in the official product labels.

What Is Semaglutide? Ozempic, Wegovy, Rybelsus

1. The Short Answer

Semaglutide is an active ingredient used in prescription GLP-1 receptor agonist medicines. In the U.S., it is sold under brand names including Ozempic, Wegovy, and Rybelsus. While the molecule is the same, the products and their specific approved uses are not interchangeable.

People often use “Ozempic,” “semaglutide,” and “GLP-1” interchangeably, but they mean different things:

Term	What it means	What it does not tell you
Semaglutide	The active ingredient.	Brand, route, indication, dose, or whether a product is appropriate.
Ozempic	A semaglutide brand for type 2 diabetes.	That every semaglutide product is Ozempic.
Wegovy	A semaglutide brand for weight management and related labeled uses.	That it has the same label as Ozempic.
Rybelsus	An oral semaglutide brand for type 2 diabetes.	That every oral semaglutide tablet has the same brand or role.
GLP-1 receptor agonist	The medication class.	The full label, route, patient population, or warnings for a product.

2. What Does GLP-1 Receptor Agonist Mean?

DailyMed describes Ozempic injection, Rybelsus and Ozempic tablets, and Wegovy as glucagon-like peptide-1, or GLP-1, receptor agonists. The Wegovy and Ozempic labels also describe semaglutide as a GLP-1 analogue that binds to and activates the GLP-1 receptor.

A GLP-1 receptor agonist is a medicine designed to activate a receptor pathway related to glucagon-like peptide-1. The medicine is not identical to the body’s natural GLP-1 hormone, and products in this category vary in route, label, and evidence base. “GLP-1” can refer to the natural hormone, the receptor, the drug category, or a general media catch-all for metabolic drugs. For more background, see What Is a GLP-1?.

For semaglutide, the naming structure is:

Molecule: semaglutide.
Class: GLP-1 receptor agonist.
Brand: Ozempic, Wegovy, Rybelsus, or another semaglutide product.
Route: injection or oral tablet.
Label: the current prescribing information for that specific product.

Ozempic is a brand name for certain semaglutide products. The Ozempic official site describes Ozempic injection and Ozempic tablets as prescription medicines for adults with type 2 diabetes, with different use details for the pen and tablet contexts.

DailyMed’s Ozempic injection label states Ozempic is a GLP-1 receptor agonist indicated for glycemic control in adults with type 2 diabetes. It also lists cardiovascular and kidney-related risk-reduction indications in defined adult type 2 diabetes populations. The oral semaglutide label separately lists Rybelsus and Ozempic tablets as GLP-1 receptor agonists for adults with type 2 diabetes and for cardiovascular-risk reduction in high-risk adults with type 2 diabetes.

Ozempic contains semaglutide, but semaglutide is not exclusively Ozempic. The distinction matters because official U.S. materials now include both Ozempic injection pens and Ozempic oral tablets.

For brand-specific details, see What Is Ozempic? and What Is Rybelsus?.

Wegovy is another semaglutide brand. The Wegovy official site describes Wegovy injection and Wegovy tablets as prescription semaglutide medicines used alongside a reduced-calorie diet and increased physical activity for specific weight-management and cardiovascular-risk contexts.

The current DailyMed Wegovy label lists both Wegovy injection and Wegovy tablets, describes Wegovy as a GLP-1 receptor agonist, and includes indications for weight reduction and long-term weight maintenance. The injection label also includes cardiovascular-risk reduction and MASH-related contexts, while the tablet label includes weight-management and cardiovascular-risk contexts in adults.

Semaglutide can be prescribed under different brand names for different purposes. While the active ingredient is the same, the brand and label dictate how the medication is approved to be used.

See What Is Wegovy? for Wegovy-specific context.

Rybelsus is an oral semaglutide brand for type 2 diabetes. The Rybelsus official site describes Rybelsus semaglutide tablets as a prescription medicine used with diet and exercise to improve blood sugar in adults with type 2 diabetes, and to reduce the risk of major cardiovascular events in high-risk adults with type 2 diabetes.

Oral semaglutide has been part of the U.S. market for years, and current DailyMed labeling places Rybelsus and Ozempic tablets in the same oral semaglutide label family. A “semaglutide tablet” might refer to Rybelsus, Ozempic tablets, or Wegovy tablets, depending on the brand and label. An oral tablet is a specific formulation, not simply an interchangeable “pill version” of an injectable brand.

For a focused oral-brand explainer, see What Is Rybelsus?.

6. Why Oral vs Injection Route Matters

Semaglutide can be formulated as an injection or as an oral tablet. DailyMed separates Ozempic injection labeling from oral semaglutide tablet labeling, and the Wegovy label includes both injection and tablet sections. Those labels feature product-specific route, formulation, and switching guidance.

Keep in mind:

If the wording says…	The distinction
Is semaglutide injectable?	Some semaglutide products are injections.
Is semaglutide oral?	Some semaglutide products are oral tablets.
Are oral and injectable semaglutide the same product?	No. Brand, route, formulation, and label context differ.
Is the “semaglutide pill” one product?	No. Brand and label context dictate the exact product.

7. Why Brand, Route, and Label Context Matter

Ozempic is primarily associated with type 2 diabetes and includes both pen and pill formulations. Wegovy is approved for weight management and cardiovascular-risk reduction. Rybelsus is an oral therapy for type 2 diabetes. The shared active ingredient does not erase the differences in how these medications are formulated and prescribed.

In March 2024, the FDA announced a Wegovy semaglutide injection indication to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight. In March 2026, the FDA announced a higher-dose Wegovy semaglutide injection approval for certain adult weight-management use. DailyMed regularly reflects recent major label changes across semaglutide products.

Additionally, the FDA has raised concerns regarding unapproved GLP-1 drugs used for weight loss, noting that unapproved compounded semaglutide or tirzepatide products have not gone through FDA review for safety, effectiveness, or quality.

When discussing these medications, it helps to clarify four things:

Which active ingredient?
Which brand?
Which route?
Which current FDA-approved label context?

8. What Is Semaglutide FAQ

What is semaglutide in simple terms?

Semaglutide is an active ingredient used in several prescription GLP-1 receptor agonist medicines. In the United States, current labels connect semaglutide with brands including Ozempic, Wegovy, and Rybelsus, but the active ingredient alone does not indicate the product's approved use.
Is semaglutide the same as Ozempic?

No. Semaglutide is the active ingredient. Ozempic is a brand name for specific semaglutide products used in type 2 diabetes management. Wegovy and Rybelsus also contain semaglutide, but their routes and labels differ.
Is semaglutide available as a pill?

Yes. Current U.S. labeling includes oral semaglutide tablets under Rybelsus, Ozempic, and Wegovy. Tablet products have their own specific labels and are not interchangeable with injectable products.
How are Ozempic, Wegovy, and Rybelsus different?

They are distinct brands of semaglutide. Ozempic is indicated for type 2 diabetes, Wegovy for weight management and related cardiovascular contexts, and Rybelsus is an oral formulation for type 2 diabetes. Exact indications are found in the official product labels.

9. Sources

References used for this article